| Mrs Patricia A Petitpas, APRN/PCNS | |
|
900 Reservoir Ave, Cranston, RI 02910-4453 | |
| (401) 944-0194 | |
| (401) 944-0196 |
| Full Name | Mrs Patricia A Petitpas |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 900 Reservoir Ave, Cranston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457446593 | NPI | - | NPPES |
| 0000032309 | Other | RI | RI BLUE CROSS PROVIDER # |
| 0000032309 | Other | RI | RI BC/BS PRVD.# |
| 6228710 | Other | RI | UNITED HEALTH |
| 413965 | Other | RI | RI BLUE CHIP PROVIDER # |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Patricia A Petitpas, APRN/PCNS 60 Metropolitan Drive, Warwick, RI 02886-7922 Ph: (401) 738-1820 | Mrs Patricia A Petitpas, APRN/PCNS 900 Reservoir Ave, Cranston, RI 02910-4453 Ph: (401) 944-0194 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
"The health of children is harmed when families are forced to choose between medical care and basic household necessities such as food, rent and utilities, a new study found," HealthDay News/U.S. News & World Report writes. "The study included 6,447 low-income caregivers with children ranging in age from newborn to 3 years.
While Intermittent fasting may sound like another dieting craze, the practice of routinely not eating and drinking for short periods of time has shown again to lead to potentially better health outcomes.
ImmunoCellular Therapeutics, Ltd. announced that updated efficacy and safety data from the phase II trial of dendritic cell-based immunotherapeutic vaccine ICT-107 in patients with newly diagnosed glioblastoma multiforme (GBM) were presented at the 2014 American Society for Clinical Oncology (ASCO) annual meeting in Chicago.
Researchers from LSU Health Sciences Center New Orleans School of Public Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Harvard School of Public Health, Brigham and Women's Hospital, and Harvard Medical School, have found for the first time that drinking more than 5 servings of sugar- sweetened cola a week prior to pregnancy appears to significantly elevate the risk of developing diabetes during pregnancy.
› Verified 2 days ago